| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Vessel Prosthesis Implantation | 63 | 2025 | 239 | 15.750 |
Why?
|
| Endovascular Procedures | 56 | 2025 | 334 | 15.070 |
Why?
|
| Aortic Aneurysm, Abdominal | 41 | 2025 | 121 | 11.970 |
Why?
|
| Blood Vessel Prosthesis | 47 | 2025 | 248 | 8.800 |
Why?
|
| Stents | 43 | 2025 | 422 | 6.610 |
Why?
|
| Aortic Aneurysm, Thoracic | 23 | 2025 | 98 | 5.690 |
Why?
|
| Aortic Rupture | 14 | 2024 | 58 | 4.140 |
Why?
|
| Endoleak | 21 | 2024 | 42 | 3.920 |
Why?
|
| Prosthesis Design | 31 | 2025 | 311 | 3.790 |
Why?
|
| Iliac Aneurysm | 6 | 2024 | 8 | 2.620 |
Why?
|
| Aortic Aneurysm | 7 | 2025 | 82 | 2.560 |
Why?
|
| Vascular Surgical Procedures | 8 | 2025 | 152 | 2.310 |
Why?
|
| Treatment Outcome | 59 | 2025 | 9230 | 2.130 |
Why?
|
| Venous Thrombosis | 6 | 2021 | 258 | 1.960 |
Why?
|
| Arteriovenous Shunt, Surgical | 3 | 2023 | 76 | 1.910 |
Why?
|
| Aortic Diseases | 8 | 2024 | 103 | 1.780 |
Why?
|
| Registries | 20 | 2025 | 998 | 1.760 |
Why?
|
| Aorta, Thoracic | 15 | 2025 | 169 | 1.680 |
Why?
|
| Risk Factors | 38 | 2025 | 5984 | 1.650 |
Why?
|
| Arterial Occlusive Diseases | 4 | 2024 | 111 | 1.530 |
Why?
|
| Aorta | 8 | 2024 | 294 | 1.520 |
Why?
|
| Iliac Artery | 5 | 2024 | 42 | 1.350 |
Why?
|
| Humans | 116 | 2025 | 95983 | 1.270 |
Why?
|
| Femoral Artery | 3 | 2025 | 91 | 1.260 |
Why?
|
| Models, Cardiovascular | 5 | 2025 | 111 | 1.260 |
Why?
|
| Retrospective Studies | 39 | 2025 | 10309 | 1.250 |
Why?
|
| Postoperative Complications | 23 | 2025 | 2603 | 1.230 |
Why?
|
| Time Factors | 30 | 2025 | 5592 | 1.160 |
Why?
|
| Aged | 52 | 2025 | 20922 | 1.080 |
Why?
|
| Prosthesis Failure | 9 | 2024 | 127 | 1.080 |
Why?
|
| Vena Cava, Inferior | 3 | 2022 | 142 | 1.060 |
Why?
|
| Aged, 80 and over | 31 | 2025 | 7220 | 1.020 |
Why?
|
| Ultrasonography, Doppler, Duplex | 4 | 2020 | 42 | 0.960 |
Why?
|
| Vascular Diseases | 2 | 2020 | 122 | 0.930 |
Why?
|
| Dissection | 1 | 2025 | 45 | 0.910 |
Why?
|
| Catheterization, Peripheral | 4 | 2020 | 64 | 0.890 |
Why?
|
| Patient-Specific Modeling | 3 | 2025 | 24 | 0.890 |
Why?
|
| Anastomosis, Surgical | 2 | 2025 | 284 | 0.880 |
Why?
|
| Male | 63 | 2025 | 45784 | 0.870 |
Why?
|
| Lost to Follow-Up | 1 | 2024 | 15 | 0.840 |
Why?
|
| Risk Assessment | 21 | 2024 | 2493 | 0.830 |
Why?
|
| Aorta, Abdominal | 5 | 2021 | 60 | 0.820 |
Why?
|
| Education, Medical, Undergraduate | 2 | 2023 | 189 | 0.790 |
Why?
|
| Pneumonia, Viral | 4 | 2020 | 346 | 0.780 |
Why?
|
| Coronavirus Infections | 4 | 2020 | 334 | 0.780 |
Why?
|
| Social Determinants of Health | 1 | 2024 | 111 | 0.750 |
Why?
|
| Female | 55 | 2025 | 49971 | 0.730 |
Why?
|
| Endarterectomy, Carotid | 3 | 2020 | 76 | 0.730 |
Why?
|
| Vascular Patency | 6 | 2024 | 127 | 0.720 |
Why?
|
| Lower Extremity | 2 | 2012 | 98 | 0.700 |
Why?
|
| Self Expandable Metallic Stents | 1 | 2020 | 7 | 0.670 |
Why?
|
| Kidney Pelvis | 1 | 2021 | 52 | 0.660 |
Why?
|
| Carotid Stenosis | 2 | 2020 | 115 | 0.650 |
Why?
|
| Peripheral Vascular Diseases | 2 | 2012 | 62 | 0.650 |
Why?
|
| Coronary Stenosis | 1 | 2020 | 39 | 0.650 |
Why?
|
| Angioplasty | 4 | 2006 | 69 | 0.650 |
Why?
|
| Carotid Artery, Internal | 1 | 2020 | 70 | 0.650 |
Why?
|
| Situs Inversus | 1 | 2020 | 16 | 0.650 |
Why?
|
| Jehovah's Witnesses | 1 | 2020 | 21 | 0.640 |
Why?
|
| Collateral Circulation | 1 | 2020 | 40 | 0.640 |
Why?
|
| Education, Medical | 1 | 2023 | 252 | 0.630 |
Why?
|
| Prosthesis-Related Infections | 3 | 2021 | 62 | 0.630 |
Why?
|
| Upper Extremity | 1 | 2020 | 65 | 0.630 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2020 | 92 | 0.620 |
Why?
|
| Aortography | 10 | 2025 | 67 | 0.620 |
Why?
|
| Betacoronavirus | 4 | 2020 | 284 | 0.600 |
Why?
|
| Robotic Surgical Procedures | 1 | 2025 | 367 | 0.590 |
Why?
|
| Middle Aged | 36 | 2025 | 28296 | 0.580 |
Why?
|
| Terminology as Topic | 2 | 2023 | 227 | 0.580 |
Why?
|
| Renal Dialysis | 3 | 2023 | 364 | 0.570 |
Why?
|
| Leg | 2 | 2013 | 143 | 0.570 |
Why?
|
| Kidney Diseases | 1 | 2021 | 323 | 0.560 |
Why?
|
| Iliac Vein | 2 | 2010 | 32 | 0.550 |
Why?
|
| Clinical Trials as Topic | 2 | 2020 | 1166 | 0.530 |
Why?
|
| Embolization, Therapeutic | 1 | 2020 | 279 | 0.520 |
Why?
|
| Physicians | 2 | 2021 | 707 | 0.520 |
Why?
|
| Finite Element Analysis | 5 | 2025 | 80 | 0.510 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2013 | 647 | 0.490 |
Why?
|
| Coronary Artery Disease | 1 | 2020 | 389 | 0.470 |
Why?
|
| Device Removal | 2 | 2021 | 169 | 0.470 |
Why?
|
| Computed Tomography Angiography | 6 | 2025 | 166 | 0.460 |
Why?
|
| Aneurysm, Infected | 3 | 2010 | 15 | 0.460 |
Why?
|
| Patient Transfer | 1 | 2016 | 108 | 0.450 |
Why?
|
| Aneurysm | 2 | 2015 | 61 | 0.440 |
Why?
|
| Aneurysm, Ruptured | 3 | 2020 | 62 | 0.430 |
Why?
|
| Surgery Department, Hospital | 3 | 2020 | 43 | 0.410 |
Why?
|
| Graft Occlusion, Vascular | 5 | 2020 | 100 | 0.410 |
Why?
|
| Leg Ulcer | 1 | 2012 | 7 | 0.380 |
Why?
|
| Healthcare Disparities | 3 | 2024 | 492 | 0.380 |
Why?
|
| Diabetic Angiopathies | 1 | 2012 | 37 | 0.370 |
Why?
|
| Embolic Protection Devices | 1 | 2012 | 9 | 0.370 |
Why?
|
| Anticoagulants | 2 | 2013 | 465 | 0.370 |
Why?
|
| Heparin | 1 | 2013 | 187 | 0.370 |
Why?
|
| Embolism | 1 | 2012 | 34 | 0.370 |
Why?
|
| Transducers, Pressure | 3 | 2011 | 6 | 0.360 |
Why?
|
| Pandemics | 5 | 2020 | 879 | 0.360 |
Why?
|
| Equipment Failure Analysis | 1 | 2012 | 93 | 0.360 |
Why?
|
| Limb Salvage | 1 | 2012 | 38 | 0.350 |
Why?
|
| United States | 12 | 2023 | 7777 | 0.350 |
Why?
|
| Reoperation | 7 | 2021 | 712 | 0.350 |
Why?
|
| Catheters, Indwelling | 1 | 2012 | 113 | 0.350 |
Why?
|
| Delivery of Health Care | 1 | 2016 | 468 | 0.350 |
Why?
|
| Tomography, X-Ray Computed | 10 | 2020 | 2777 | 0.340 |
Why?
|
| Fibromuscular Dysplasia | 1 | 2011 | 11 | 0.340 |
Why?
|
| Monitoring, Ambulatory | 1 | 2011 | 33 | 0.330 |
Why?
|
| Septal Occluder Device | 1 | 2011 | 57 | 0.330 |
Why?
|
| Cardiovascular Agents | 1 | 2011 | 61 | 0.320 |
Why?
|
| Bicycling | 1 | 2010 | 16 | 0.320 |
Why?
|
| Carotid Artery Diseases | 1 | 2011 | 102 | 0.310 |
Why?
|
| Cerebrovascular Disorders | 1 | 2011 | 146 | 0.310 |
Why?
|
| Stroke | 5 | 2023 | 1088 | 0.300 |
Why?
|
| Predictive Value of Tests | 4 | 2023 | 1817 | 0.300 |
Why?
|
| Health Status Disparities | 2 | 2023 | 220 | 0.290 |
Why?
|
| Sex Factors | 5 | 2020 | 1129 | 0.290 |
Why?
|
| Foreign-Body Migration | 2 | 2024 | 34 | 0.290 |
Why?
|
| Balloon Occlusion | 2 | 2005 | 33 | 0.280 |
Why?
|
| Subclavian Artery | 4 | 2021 | 42 | 0.280 |
Why?
|
| Kidney Failure, Chronic | 1 | 2012 | 432 | 0.270 |
Why?
|
| Fibrinolytic Agents | 4 | 2011 | 240 | 0.260 |
Why?
|
| Diverticulum | 2 | 2020 | 45 | 0.260 |
Why?
|
| Multiple Trauma | 2 | 2006 | 38 | 0.260 |
Why?
|
| Groin | 2 | 2025 | 11 | 0.260 |
Why?
|
| Nephrectomy | 1 | 2009 | 297 | 0.250 |
Why?
|
| Thyroid Neoplasms | 1 | 2011 | 443 | 0.250 |
Why?
|
| Vascular Fistula | 2 | 2020 | 12 | 0.250 |
Why?
|
| Telemetry | 1 | 2006 | 36 | 0.240 |
Why?
|
| Deglutition Disorders | 2 | 2020 | 126 | 0.240 |
Why?
|
| Wounds, Nonpenetrating | 2 | 2006 | 118 | 0.230 |
Why?
|
| Incidence | 3 | 2020 | 1722 | 0.230 |
Why?
|
| Aneurysm, False | 2 | 2010 | 55 | 0.230 |
Why?
|
| Bloodless Medical and Surgical Procedures | 1 | 2025 | 6 | 0.220 |
Why?
|
| Cadaver | 1 | 2025 | 204 | 0.220 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2009 | 366 | 0.220 |
Why?
|
| Postoperative Care | 1 | 2006 | 239 | 0.220 |
Why?
|
| Metals | 1 | 2025 | 102 | 0.220 |
Why?
|
| Angioplasty, Balloon | 3 | 2012 | 98 | 0.220 |
Why?
|
| Treatment Refusal | 1 | 2025 | 68 | 0.210 |
Why?
|
| Lithotripsy | 1 | 2024 | 45 | 0.210 |
Why?
|
| Consensus | 2 | 2019 | 372 | 0.210 |
Why?
|
| Intraoperative Complications | 3 | 2010 | 197 | 0.210 |
Why?
|
| Blood Pressure Monitors | 1 | 2004 | 10 | 0.210 |
Why?
|
| Blood Loss, Surgical | 1 | 2025 | 133 | 0.210 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2004 | 18 | 0.210 |
Why?
|
| Blood Pressure Determination | 1 | 2004 | 69 | 0.210 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 2004 | 20 | 0.210 |
Why?
|
| Comorbidity | 5 | 2020 | 1017 | 0.200 |
Why?
|
| Quality of Life | 1 | 2012 | 1816 | 0.200 |
Why?
|
| Blood Transfusion | 1 | 2025 | 180 | 0.200 |
Why?
|
| Kidney Neoplasms | 1 | 2009 | 557 | 0.200 |
Why?
|
| Thrombosis | 2 | 2018 | 326 | 0.200 |
Why?
|
| Thrombolytic Therapy | 2 | 2020 | 261 | 0.200 |
Why?
|
| Europe | 3 | 2020 | 351 | 0.200 |
Why?
|
| Hemostasis, Surgical | 1 | 2003 | 25 | 0.200 |
Why?
|
| Stress, Mechanical | 2 | 2025 | 261 | 0.200 |
Why?
|
| Feasibility Studies | 1 | 2025 | 819 | 0.190 |
Why?
|
| Surgical Wound Infection | 1 | 2025 | 237 | 0.190 |
Why?
|
| Patient Selection | 2 | 2020 | 708 | 0.190 |
Why?
|
| Arteries | 2 | 2022 | 181 | 0.190 |
Why?
|
| Hospital Costs | 1 | 2023 | 117 | 0.190 |
Why?
|
| Ulcer | 2 | 2020 | 38 | 0.190 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2004 | 364 | 0.180 |
Why?
|
| Staphylococcus aureus | 1 | 2005 | 285 | 0.180 |
Why?
|
| Radiography | 4 | 2012 | 823 | 0.180 |
Why?
|
| Mentors | 1 | 2023 | 101 | 0.180 |
Why?
|
| Retreatment | 2 | 2021 | 107 | 0.180 |
Why?
|
| Infection Control | 2 | 2020 | 132 | 0.180 |
Why?
|
| Ischemia | 1 | 2004 | 256 | 0.180 |
Why?
|
| Schools, Medical | 1 | 2023 | 144 | 0.180 |
Why?
|
| Saphenous Vein | 1 | 2021 | 61 | 0.180 |
Why?
|
| Hematoma | 2 | 2020 | 109 | 0.180 |
Why?
|
| Spinal Cord Ischemia | 1 | 2021 | 8 | 0.180 |
Why?
|
| Sex Distribution | 2 | 2020 | 176 | 0.180 |
Why?
|
| Students | 1 | 2023 | 179 | 0.170 |
Why?
|
| Staphylococcal Infections | 1 | 2004 | 289 | 0.170 |
Why?
|
| Socioeconomic Factors | 1 | 2024 | 639 | 0.170 |
Why?
|
| Dilatation | 1 | 2021 | 48 | 0.170 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2018 | 890 | 0.170 |
Why?
|
| Treatment Failure | 2 | 2012 | 297 | 0.170 |
Why?
|
| Cardiovascular Abnormalities | 2 | 2015 | 8 | 0.170 |
Why?
|
| Connective Tissue Diseases | 1 | 2021 | 75 | 0.170 |
Why?
|
| Phlebography | 2 | 2011 | 68 | 0.160 |
Why?
|
| Intestines | 1 | 2004 | 432 | 0.160 |
Why?
|
| Clinical Decision-Making | 1 | 2023 | 296 | 0.160 |
Why?
|
| Intestinal Fistula | 1 | 2020 | 31 | 0.160 |
Why?
|
| Needs Assessment | 1 | 2021 | 171 | 0.160 |
Why?
|
| Guideline Adherence | 2 | 2013 | 245 | 0.160 |
Why?
|
| Clinical Competence | 1 | 2006 | 858 | 0.160 |
Why?
|
| Clinical Clerkship | 1 | 2021 | 125 | 0.160 |
Why?
|
| Medicare | 1 | 2023 | 458 | 0.160 |
Why?
|
| Regional Blood Flow | 1 | 2020 | 198 | 0.160 |
Why?
|
| Catheters | 1 | 2020 | 96 | 0.160 |
Why?
|
| Cysts | 2 | 2015 | 104 | 0.150 |
Why?
|
| Body Mass Index | 1 | 2023 | 816 | 0.150 |
Why?
|
| Magnetic Resonance Angiography | 4 | 2023 | 277 | 0.150 |
Why?
|
| Disease Transmission, Infectious | 1 | 2020 | 60 | 0.150 |
Why?
|
| Health Resources | 1 | 2020 | 82 | 0.150 |
Why?
|
| Blood Flow Velocity | 1 | 2019 | 201 | 0.150 |
Why?
|
| Cause of Death | 2 | 2018 | 278 | 0.150 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2011 | 180 | 0.140 |
Why?
|
| Death Certificates | 1 | 2018 | 11 | 0.140 |
Why?
|
| Coronary Artery Bypass | 1 | 2020 | 252 | 0.140 |
Why?
|
| New Zealand | 1 | 2018 | 24 | 0.140 |
Why?
|
| Thrombectomy | 1 | 2020 | 220 | 0.140 |
Why?
|
| Device Approval | 1 | 2018 | 14 | 0.140 |
Why?
|
| Brazil | 1 | 2018 | 83 | 0.140 |
Why?
|
| Severity of Illness Index | 2 | 2023 | 1982 | 0.140 |
Why?
|
| Australia | 1 | 2018 | 125 | 0.140 |
Why?
|
| Physician-Patient Relations | 1 | 2023 | 636 | 0.140 |
Why?
|
| Age Distribution | 1 | 2018 | 210 | 0.130 |
Why?
|
| Surgical Procedures, Operative | 1 | 2020 | 219 | 0.130 |
Why?
|
| Biomechanical Phenomena | 1 | 2019 | 506 | 0.130 |
Why?
|
| Diabetic Foot | 1 | 2017 | 16 | 0.130 |
Why?
|
| Informed Consent | 1 | 2020 | 281 | 0.130 |
Why?
|
| Diffusion of Innovation | 1 | 2018 | 79 | 0.130 |
Why?
|
| Databases, Factual | 2 | 2020 | 1014 | 0.130 |
Why?
|
| General Surgery | 1 | 2020 | 255 | 0.130 |
Why?
|
| Chi-Square Distribution | 1 | 2018 | 365 | 0.130 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2020 | 472 | 0.130 |
Why?
|
| Constriction, Pathologic | 2 | 2010 | 219 | 0.130 |
Why?
|
| United States Food and Drug Administration | 1 | 2018 | 146 | 0.130 |
Why?
|
| Guidelines as Topic | 1 | 2017 | 169 | 0.120 |
Why?
|
| Obesity | 1 | 2023 | 1029 | 0.120 |
Why?
|
| Adult | 10 | 2024 | 28630 | 0.120 |
Why?
|
| Education, Medical, Graduate | 1 | 2020 | 438 | 0.120 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2020 | 633 | 0.120 |
Why?
|
| Students, Medical | 1 | 2021 | 455 | 0.120 |
Why?
|
| Hospitals, High-Volume | 1 | 2016 | 43 | 0.120 |
Why?
|
| Chronic Disease | 1 | 2019 | 984 | 0.120 |
Why?
|
| Acute Disease | 3 | 2025 | 859 | 0.110 |
Why?
|
| Goals | 1 | 2015 | 68 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 2 | 2013 | 1095 | 0.110 |
Why?
|
| Vascular Malformations | 1 | 2015 | 19 | 0.110 |
Why?
|
| Time-to-Treatment | 1 | 2016 | 140 | 0.110 |
Why?
|
| Decision Making | 1 | 2020 | 695 | 0.110 |
Why?
|
| Follow-Up Studies | 4 | 2020 | 3922 | 0.100 |
Why?
|
| Heart-Assist Devices | 1 | 2022 | 903 | 0.100 |
Why?
|
| Prospective Studies | 5 | 2024 | 4691 | 0.100 |
Why?
|
| Swine | 2 | 2004 | 607 | 0.090 |
Why?
|
| Suture Techniques | 2 | 2024 | 143 | 0.090 |
Why?
|
| Health Care Surveys | 1 | 2013 | 295 | 0.090 |
Why?
|
| Vena Cava Filters | 1 | 2013 | 90 | 0.090 |
Why?
|
| Equipment Design | 2 | 2011 | 435 | 0.090 |
Why?
|
| Algorithms | 1 | 2020 | 2019 | 0.090 |
Why?
|
| Ankle Brachial Index | 1 | 2012 | 27 | 0.090 |
Why?
|
| Research Design | 1 | 2015 | 630 | 0.090 |
Why?
|
| Drug Administration Schedule | 1 | 2013 | 857 | 0.090 |
Why?
|
| Pyoderma Gangrenosum | 1 | 2011 | 20 | 0.090 |
Why?
|
| Illinois | 1 | 2013 | 530 | 0.090 |
Why?
|
| Carotid Artery, Common | 1 | 2011 | 28 | 0.090 |
Why?
|
| Emergency Medical Services | 1 | 2014 | 271 | 0.090 |
Why?
|
| Bronchial Fistula | 1 | 2011 | 10 | 0.090 |
Why?
|
| Neck Dissection | 1 | 2011 | 67 | 0.080 |
Why?
|
| National Health Programs | 1 | 2011 | 19 | 0.080 |
Why?
|
| Germany | 1 | 2011 | 81 | 0.080 |
Why?
|
| Internship and Residency | 1 | 2020 | 1134 | 0.080 |
Why?
|
| Asymptomatic Diseases | 1 | 2011 | 43 | 0.080 |
Why?
|
| Computer Simulation | 2 | 2025 | 1158 | 0.080 |
Why?
|
| Pressure | 1 | 2011 | 175 | 0.080 |
Why?
|
| Thyroidectomy | 1 | 2011 | 173 | 0.080 |
Why?
|
| Surveys and Questionnaires | 2 | 2021 | 2859 | 0.080 |
Why?
|
| Hypolipidemic Agents | 1 | 2011 | 98 | 0.080 |
Why?
|
| Length of Stay | 2 | 2014 | 835 | 0.080 |
Why?
|
| Triage | 2 | 2020 | 132 | 0.070 |
Why?
|
| Hospital Mortality | 3 | 2020 | 485 | 0.070 |
Why?
|
| Antihypertensive Agents | 1 | 2011 | 265 | 0.070 |
Why?
|
| Incidental Findings | 1 | 2009 | 99 | 0.070 |
Why?
|
| Angiography | 2 | 2006 | 209 | 0.070 |
Why?
|
| Evidence-Based Medicine | 1 | 2011 | 458 | 0.070 |
Why?
|
| Hypoglycemic Agents | 1 | 2011 | 376 | 0.070 |
Why?
|
| Adolescent | 4 | 2021 | 9872 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2004 | 2536 | 0.060 |
Why?
|
| Survival Rate | 3 | 2020 | 1978 | 0.060 |
Why?
|
| Accidental Falls | 1 | 2006 | 49 | 0.060 |
Why?
|
| Chicago | 2 | 2020 | 1505 | 0.060 |
Why?
|
| Forecasting | 1 | 2006 | 317 | 0.060 |
Why?
|
| Syndrome | 1 | 2006 | 450 | 0.060 |
Why?
|
| Catheterization | 1 | 2006 | 237 | 0.060 |
Why?
|
| Hepatic Veins | 1 | 2004 | 27 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2011 | 1464 | 0.050 |
Why?
|
| Intestine, Small | 1 | 2006 | 310 | 0.050 |
Why?
|
| Calibration | 1 | 2004 | 108 | 0.050 |
Why?
|
| Miniaturization | 1 | 2004 | 14 | 0.050 |
Why?
|
| Fluoroscopy | 1 | 2004 | 140 | 0.050 |
Why?
|
| Constriction | 1 | 2003 | 27 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2006 | 927 | 0.050 |
Why?
|
| Critical Illness | 1 | 2005 | 346 | 0.050 |
Why?
|
| Arteriosclerosis | 1 | 2002 | 112 | 0.040 |
Why?
|
| Propensity Score | 1 | 2022 | 179 | 0.040 |
Why?
|
| Hemodynamics | 1 | 2025 | 776 | 0.040 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2003 | 99 | 0.040 |
Why?
|
| Critical Care | 1 | 2005 | 448 | 0.040 |
Why?
|
| Decision Support Techniques | 1 | 2023 | 186 | 0.040 |
Why?
|
| Peru | 1 | 2021 | 28 | 0.040 |
Why?
|
| Cognition | 1 | 2006 | 634 | 0.040 |
Why?
|
| Educational Status | 1 | 2021 | 202 | 0.040 |
Why?
|
| Georgia | 2 | 2011 | 41 | 0.040 |
Why?
|
| Calcinosis | 1 | 2002 | 230 | 0.040 |
Why?
|
| Organizational Innovation | 1 | 2020 | 47 | 0.040 |
Why?
|
| Osteogenesis | 1 | 2002 | 277 | 0.040 |
Why?
|
| Education, Distance | 1 | 2020 | 25 | 0.040 |
Why?
|
| Computer-Assisted Instruction | 1 | 2020 | 48 | 0.040 |
Why?
|
| Uncertainty | 1 | 2020 | 82 | 0.040 |
Why?
|
| Efficiency, Organizational | 1 | 2020 | 55 | 0.040 |
Why?
|
| Age Factors | 2 | 2020 | 1958 | 0.040 |
Why?
|
| Workload | 1 | 2020 | 133 | 0.040 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2020 | 102 | 0.040 |
Why?
|
| Risk | 1 | 2020 | 666 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2004 | 2887 | 0.030 |
Why?
|
| Internet | 1 | 2020 | 340 | 0.030 |
Why?
|
| Curriculum | 1 | 2021 | 616 | 0.030 |
Why?
|
| Prevalence | 1 | 2020 | 1350 | 0.030 |
Why?
|
| Animals | 2 | 2004 | 28905 | 0.030 |
Why?
|
| Prognosis | 1 | 2020 | 3994 | 0.020 |
Why?
|
| Young Adult | 1 | 2024 | 7025 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2014 | 363 | 0.020 |
Why?
|
| Leukocytosis | 1 | 2010 | 15 | 0.020 |
Why?
|
| Hospitals, University | 1 | 2011 | 199 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2010 | 217 | 0.020 |
Why?
|
| Bronchoscopy | 1 | 2011 | 175 | 0.020 |
Why?
|
| Elective Surgical Procedures | 1 | 2010 | 164 | 0.020 |
Why?
|
| Creatinine | 1 | 2009 | 299 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2010 | 904 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2014 | 3114 | 0.020 |
Why?
|
| Graft Survival | 1 | 2010 | 942 | 0.020 |
Why?
|
| Multicenter Studies as Topic | 1 | 2006 | 185 | 0.010 |
Why?
|
| Sutures | 1 | 2006 | 59 | 0.010 |
Why?
|
| Equipment Failure | 1 | 2006 | 133 | 0.010 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2005 | 171 | 0.010 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2005 | 155 | 0.010 |
Why?
|
| Accidents, Traffic | 1 | 2004 | 104 | 0.010 |
Why?
|
| Polyesters | 1 | 2003 | 44 | 0.010 |
Why?
|
| Pulmonary Embolism | 1 | 2006 | 236 | 0.010 |
Why?
|
| Child | 1 | 2015 | 7626 | 0.010 |
Why?
|
| Hepatectomy | 1 | 2004 | 178 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2006 | 1741 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2005 | 1540 | 0.010 |
Why?
|
| Demography | 1 | 2002 | 190 | 0.010 |
Why?
|
| Ischemic Attack, Transient | 1 | 2002 | 188 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2002 | 1827 | 0.010 |
Why?
|